Prospective endoscopic evaluation for gastrointestinal graft-versus-host disease: determination of the best diagnostic approach

[1]  M. Rubinger,et al.  Does gastroenterology consultation change management of patients receiving hematopoietic stem cell transplantation? , 2001, Bone Marrow Transplantation.

[2]  N. Chao,et al.  Acute graft-vs-host disease: pathobiology and management. , 2001, Experimental hematology.

[3]  R. Ponec,et al.  Endoscopic and histologic diagnosis of intestinal graft-versus-host disease after marrow transplantation. , 1999, Gastrointestinal endoscopy.

[4]  E D Thomas,et al.  1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.

[5]  A. Nadal,et al.  Assessment of histopathologic changes in the colonic biopsy in acute graft-versus-host disease. , 1995, American journal of clinical pathology.

[6]  R. Lo,et al.  Etiology and outcome of diarrhea after marrow transplantation: a prospective study. , 1994, Gastroenterology.

[7]  W. Kreisel,et al.  Diagnosis and grading of acute graft‐versus-host disease following allogeneic bone marrow transplantation by sigmoidoscopy , 1994 .

[8]  Rachel L. Mistur,et al.  Graft-Versus-Host Disease , 2016 .

[9]  D. Snover,et al.  Simultaneous upper and lower endoscopic biopsy in the diagnosis of intestinal graft-versus-host disease. , 1991, Transplantation.

[10]  H. Deeg,et al.  Graft‐versus‐host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long‐term follow‐up of a controlled trial , 1989, British journal of haematology.

[11]  H. Deeg,et al.  Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial. , 1989, Blood.

[12]  H. Deeg,et al.  Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. , 1986, The New England journal of medicine.

[13]  P. Neiman,et al.  CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.

[14]  R. Storb,et al.  METHOTREXATE REGIMENS FOR CONTROL OF GRAFT-VERSUS-HOST DISEASE IN DOGS WITH ALLOGENEIC MARROW GRAFTS , 1970, Transplantation.

[15]  A. Owens,et al.  Production of Graft-Versus-Host Disease in the Rat and its Treatment with Cytotoxic Agents , 1966, Nature.

[16]  G. McDonald,et al.  The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients. , 1980, Gastroenterology.

[17]  Slavin Re,et al.  The pathology of bone marrow transplantation. , 1974 .